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BACKGROUND: Microparticles (MPs) are small vesicles released during cell
activation or apoptosis. They are involved in coagulation, inflammation and vascular
dysfunction in several diseases. We characterized circulating MPs from Crohn's
Disease (CD) patients and evaluated their effects on endothelial function and vascular
reactivity after in vivo injection into mice.
METHODS: Circulating MPs and their cellular origins were examined by flow
cytometry from blood samples from healthy subjects (HS) and inactive or active CD
patients. MPs were intravenously injected into mice. After 24 hours, endothelial
function and vascular reactivity were assessed.
RESULTS: Circulating MP levels did not differ between HS and inactive CD patients
except for an increase in leukocyte-derived MPs in CD. Active CD patients compared
to HS displayed increased total circulating MPs, pro-coagulant MPs and those from
platelets, endothelium, erythrocytes, leukocytes, activated leukocytes and activated
platelets. A significant correlation was found between total levels of MPs, those from
platelets and endothelial cells, and the Harvey-Bradshaw clinical activity index. MPs
from CD, but not from HS, impaired endothelium-dependent relaxation in mice aorta
and flow-induced dilation in mice small mesenteric arteries, MPs from inactive CD
patients being more effective than those from active patients. CDMPs induced
vascular hypo-reactivity in aorta that was prevented by a nitric oxide (NO)-synthase
inhibitor, and was associated with a subtle alteration of the balance between NO,
reactive oxygen species and the release of COX metabolites.
CONCLUSIONS: We provide evidence that MPs from CD patients significantly alter
endothelial and vascular function and therefore, may play a role in CD
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